BOSTON & SHANGHAI, September 2, 2024 – Skyline Therapeutics, a gene therapy company focused on innovative treatments for rare and severe diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for SKG1108....
Company will present data from its successful rejuvenation of fibroblasts and keratinocytes to influential gathering of international dermatologists MOUNTAIN VIEW, Calif., Sept. 4, 2024 /PRNewswire/ — Turn Biotechnologies, a developer of novel mRNA medicines and...
In the rapidly advancing world of medicine, recent breakthroughs in cell and gene therapy are revolutionizing the treatment of cancer and genetic diseases. These therapies, encompassing viral and nonviral vectors as well as mRNA, are transforming how we approach these...
Cardinal Health has inaugurated its Advanced Therapy Innovation Center in La Vergne, Tennessee. The 8,000-square-foot facility, part of a larger distribution center, is designed to address the specialized logistics needs of cell and gene therapies. “The opening of...
Tern Therapeutics, a new biotech startup, officially launched on August 27, 2024, with $15 million in funding to advance gene therapies targeting Batten disease, specifically the ceroid lipofuscinosis type 2 (CLN2) form. This neurodegenerative disorder leads to vision...
